Ignite Creation Date:
2025-12-24 @ 3:25 PM
Ignite Modification Date:
2026-02-23 @ 9:22 PM
Study NCT ID:
NCT00649792
Status:
COMPLETED
Last Update Posted:
2012-02-28
First Post:
2008-03-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial
Sponsor:
Acorda Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MS-F204 EXT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None